Samsung Life Insurance Co., Ltd. (KRX:032830)
237,000
-9,000 (-3.66%)
Feb 26, 2026, 12:30 PM KST
Samsung Life Insurance Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 11,674,967 | 11,108,560 | 10,123,969 | 13,311,664 | 17,749,241 |
Total Interest & Dividend Income | 9,954,285 | 9,926,526 | 9,786,898 | 9,586,989 | 8,462,622 |
Gain (Loss) on Sale of Investments | 7,236,997 | 3,007,414 | 4,345,918 | 1,089,610 | 465,563 |
Other Revenue | 5,975,905 | 4,645,260 | 5,004,762 | 7,081,951 | 4,563,040 |
| 34,842,154 | 28,687,760 | 29,261,547 | 31,070,214 | 31,240,466 | |
Revenue Growth (YoY) | 21.45% | -1.96% | -5.82% | -0.55% | -2.83% |
Policy Benefits | 15,355,802 | 11,326,286 | 15,590,095 | 12,104,636 | 20,883,833 |
Policy Acquisition & Underwriting Costs | 150,584 | 141,118 | -2,011,961 | -1,675,742 | 547,761 |
Amortization of Goodwill & Intangibles | 76,983 | 80,268 | 80,867 | 129,451 | 146,203 |
Depreciation & Amortization | 289,555 | 273,525 | 273,916 | 288,191 | 284,858 |
Selling, General & Administrative | 2,337,563 | 2,068,707 | 1,542,863 | 1,083,523 | 731,982 |
Other Operating Expenses | 10,155,112 | 11,314,829 | 8,113,178 | 10,997,211 | 5,600,896 |
Reinsurance Income or Expense | -271,226 | -241,198 | -203,178 | -175,982 | -588,308 |
Total Operating Expenses | 30,366,783 | 27,103,702 | 25,416,530 | 24,388,821 | 30,054,280 |
Operating Income | 4,475,371 | 1,584,058 | 3,845,017 | 6,681,393 | 1,186,186 |
Interest Expense | -1,908,207 | -1,788,350 | -1,538,797 | -1,119,209 | -611,484 |
Earnings From Equity Investments | 415,410 | 301,728 | 153,974 | 142,238 | 354,543 |
Currency Exchange Gain (Loss) | 781,803 | 4,305,640 | 948,197 | 1,500,733 | 1,313,249 |
Other Non Operating Income (Expenses) | 1,537 | -3,325 | 8,163 | -117,203 | -20,026 |
EBT Excluding Unusual Items | 3,765,914 | 4,399,751 | 3,416,554 | 7,087,952 | 2,222,468 |
Gain (Loss) on Sale of Investments | -768,498 | -1,601,597 | -856,040 | -4,882,190 | -186,928 |
Gain (Loss) on Sale of Assets | 531 | 18,616 | -119 | 233,316 | 1,404 |
Asset Writedown | -1,602 | -3,104 | -1,344 | 1,386 | -2,727 |
Pretax Income | 2,996,345 | 2,813,666 | 2,559,051 | 2,440,464 | 2,034,217 |
Income Tax Expense | 544,830 | 553,411 | 525,342 | 132,867 | 436,515 |
Earnings From Continuing Ops. | 2,451,515 | 2,260,255 | 2,033,709 | 2,307,597 | 1,597,702 |
Minority Interest in Earnings | -148,678 | -153,416 | -138,397 | -137,445 | -128,266 |
Net Income | 2,302,837 | 2,106,839 | 1,895,312 | 2,170,152 | 1,469,436 |
Net Income to Common | 2,302,837 | 2,106,839 | 1,895,312 | 2,170,152 | 1,469,436 |
Net Income Growth | 9.30% | 11.16% | -12.67% | 47.69% | 16.09% |
Shares Outstanding (Basic) | 180 | 180 | 180 | 180 | 180 |
Shares Outstanding (Diluted) | 180 | 180 | 180 | 180 | 180 |
Shares Change (YoY) | -0.01% | 0.00% | - | - | - |
EPS (Basic) | 12824.00 | 11732.00 | 10554.44 | 12084.95 | 8182.86 |
EPS (Diluted) | 12824.00 | 11732.00 | 10554.00 | 12084.95 | 8182.86 |
EPS Growth | 9.31% | 11.16% | -12.67% | 47.69% | 16.09% |
Free Cash Flow | 5,026,213 | 4,847,720 | 544,869 | 756,602 | 2,485,003 |
Free Cash Flow Per Share | 27989.89 | 26994.68 | 3034.22 | 4213.30 | 13838.26 |
Operating Margin | 12.85% | 5.52% | 13.14% | 21.50% | 3.80% |
Profit Margin | 6.61% | 7.34% | 6.48% | 6.98% | 4.70% |
Free Cash Flow Margin | 14.43% | 16.90% | 1.86% | 2.44% | 7.95% |
EBITDA | 4,783,955 | 1,878,296 | 4,121,876 | 7,008,798 | 1,651,500 |
EBITDA Margin | 13.73% | 6.55% | 14.09% | 22.56% | 5.29% |
D&A For EBITDA | 308,584 | 294,238 | 276,859 | 327,405 | 465,314 |
EBIT | 4,475,371 | 1,584,058 | 3,845,017 | 6,681,393 | 1,186,186 |
EBIT Margin | 12.85% | 5.52% | 13.14% | 21.50% | 3.80% |
Effective Tax Rate | 18.18% | 19.67% | 20.53% | 5.44% | 21.46% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.